KL2/Catalyst Medical Research Investigator Training

Program Update

As of May 1, 2023, the KL2/CMeRIT program will convert to the K12/CMeRIT program. Those applicants who receive an award for the 2023 funding cycle will fall under the new K12 structure, with funding to commence on October 1, 2023. Information on the K12 funding mechanism can be found on the NIH website.

The KL2/Catalyst Medical Research Investigator Training (CMeRIT) program provides advanced training in clinical and translational research to senior fellows and junior faculty from all health professions represented by Harvard Catalyst, including medicine, dentistry, and nursing.

Awardees will pursue a mentored research project in their area of expertise. It is expected that the research performed within the KL2/CMeRIT program will provide the basis for an independent NIH award (e.g., K23, KO8, or RO1).

Awardees will also pursue an educational program that fulfills the mission of the program and provides optimal training in their chosen career objectives. They may do this by taking part in the courses found in LearnResearch where applicable, or by participating in Harvard Catalyst-based courses.

Mentoring and Program Oversight

Each awardee will work with their mentor to develop and execute a work plan for their research project. Mentors must be accomplished investigators in clinical and translational research and have a track record of success in training new investigators and fostering their success as independent researchers. An advisory committee will connect each awardee with a group of experienced clinicians and researchers to provide additional resources in the fields of genetics, biostatistics, biomarkers, and imaging.